Objective: It is important to determine the risk factors for the development of asthma in patients with recurrent wheezing (RW). This study was intended to compare the lung functions of children with RW with and without Asthma Predictive Index (API) positivity. Methods: This prospective cross-sectional study included 40 children with RW aged between 3 months and 3 years and 34 age- and sex-matched healthy controls (HC). Lung functions were measured using tidal breath analysis during the wheezing attack in the RW group. Peak tidal expiratory flow time (TPTEF), ratio of peak tidal expiratory flow time to expiratory time (TPTEF/TE), volume required for PTEF (VPTEF), ratio of volume required for PTEF to expiratory volume (VPTEF/VE), tidal volume/kg (VT/kg), inspiratory to expiratory ratio (TI/TE), inspiratory time (TI), and expiratory time (TE) represented the main tidal breath analysis parameters. API positivity was also calculated in the RW group. Results: TPTEF, VPTEF, TPTEF/TE, VPEF/VE, TI, and TI/TE were all lower in the RW group than in the HC group (p<0.05). However, there was no difference in TPTEF/TE between the RW patients with positive and negative API. TPTEF and TE parameters were higher in the RW group with positive API (p=0.026 and p=0.043, respectively). Conclusion: Greater bronchial obstruction was observed in the RW group compared to the HC group. No difference in bronchial obstruction was detected between the RW group with positive API and the negative API group. API positivity during wheezing attacks did not emerge as an important parameter in terms of decreased lung functions in this study.
2 February 2026 in Pediatric Allergy and Immunology
Objective: Although coronavirus disease 2019 (COVID‐19) usually exhibits a mild clinical course in children, concerns remain regarding persistent airway dysfunction after recovery. This study aimed to evaluate pulmonary function tests (PFTs) in children following mild COVID‐19 infection and to compare the findings with those of healthy controls. Methods: In this prospective cross‐sectional study, children aged 6–18 years with polymerase chain reaction–confirmed COVID‐19 infection were identified retrospectively from February 2022 and evaluated prospectively between June and December 2022. Fifty‐eight post‐COVID‐19 patients and 56 age‐ and sex‐matched healthy controls were included, and their demographic and clinical characteristics were recorded. PFTs were assessed using impulse oscillometry (IOS) followed by spirometry. Results: There were no significant differences in demographic and anthropometric measurements between the post‐COVID‐19 group and the healthy controls. In terms of IOS measurements, zR5 and R5‐20 (reflecting airway resistance) were higher and zX5 and zX20 (reflecting airway reactance) were lower in the post‐COVID‐19 group ( p = .006, p = .002, p < .001, and p = .001, respectively). No significant differences were observed in spirometric parameters, including zFEV1, zFVC, zFEV1/FVC, and zFEF25–75. Notably, three patients exhibited persistent cough and dyspnea after COVID‐19, had FEV1 values <90% predicted, positive bronchodilator reversibility, and inhalant allergen sensitization despite having no prior history of asthma or allergic rhinitis. Conclusion: Children recovering from mild COVID‐19 infection may exhibit persistent airway dysfunction detectable by IOS despite normal spirometric findings. IOS appears to be a sensitive tool for identifying subclinical airway involvement in children following COVID‐19.